| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| Multum Therapeutic Sub-class number 1 for TC1 | MIDUS | Treatment |
Treatment for all conditions |
Studies in LINKAGE |
|
| # | Datatype | Datatype value list datatype |
|---|---|---|
|
|
Value List | Number |
| # | Permissible value | Value meaning name |
|---|---|---|
|
|
2 | Amebecides |
|
|
4 | Antifungals |
|
|
6 | Antituberculosis agents |
|
|
7 | Antiviral agents |
|
|
9 | Cephalosporins |
|
|
11 | Macrolide derivatives |
|
|
12 | Miscellaneous antibiotics |
|
|
13 | Penicillins |
|
|
14 | Quinolones |
|
|
15 | Sulfonamides |
|
|
17 | Urinary anti-infectives |
|
|
18 | Aminoglycosides |
|
|
19 | Antihyperlipidemic agents |
|
|
23 | Antimetabolites |
|
|
24 | Antineoplastic hormones |
|
|
42 | Angiotensin converting enzyme inhibitors |
|
|
43 | Antiadrenergic agents, peripherally acting |
|
|
45 | Antianginal agents |
|
|
46 | Antiarrhythmic agents |
|
|
47 | Beta-adrenergic blocking agents |
|
|
48 | Calcium channel blocking agents |
|
|
49 | Diuretics |
|
|
50 | Inotropic agents |
|
|
51 | Miscellaneous cardiovascular agents |
|
|
53 | Vasodilators |
|
|
55 | Antihypertensive combinations |
|
|
56 | Angiotensin II inhibitors |
|
|
58 | Analgesics |
|
|
61 | Nonsteroidal anti-inflammatory agents |
|
|
62 | Salicylates |
|
|
63 | Analgesic combinations |
|
|
64 | Anticonvulsants |
|
|
65 | Antiemetic/antivertigo agents |
|
|
66 | Antiparkinson agents |
|
|
67 | Anxiolytics, sedatives, and hypnotics |
|
|
69 | Benzodiazepines |
|
|
70 | Miscellaneous anxiolytics, sedatives and hypnotics |
|
|
73 | Muscle relaxants |
|
|
74 | Neuromuscular blocking agents |
|
|
77 | Miscellaneous antipsychotic agents |
|
|
82 | Anticoagulants |
|
|
83 | Antiplatelet agents |
|
|
85 | Miscellaneous coagulation modifiers |
|
|
88 | Antacids |
|
|
90 | Antidiarrheals |
|
|
91 | Digestive enzymes |
|
|
92 | Gallstone solubilizing agents |
|
|
93 | GI stimulants |
|
|
94 | H2 antagonists |
|
|
95 | Laxatives |
|
|
96 | Miscellaneous GI agents |
|
|
98 | Adrenal cortical steroids |
|
|
99 | Antidiabetic agents |
|
|
101 | Sex hormones |
|
|
103 | Thyroid hormones |
|
|
104 | Immunosuppressive agents |
|
|
107 | Chelating agents |
|
|
110 | Miscellaneous uncategorized agents |
|
|
116 | Iron products |
|
|
117 | Minerals and electrolytes |
|
|
118 | Oral nutritional supplements |
|
|
119 | Vitamins |
|
|
120 | Vitamin and mineral combinations |
|
|
121 | Intravenous nutritional products |
|
|
123 | Antihistamines |
|
|
125 | Bronchodilators |
|
|
126 | Methylxanthines |
|
|
127 | Decongestants |
|
|
128 | Expectorants |
|
|
130 | Respiratory inhalant products |
|
|
132 | Upper respiratory combinations |
|
|
135 | Antiseptic and germicides |
|
|
136 | Dermatological agents |
|
|
138 | Topical steroids |
|
|
140 | Miscellaneous topical agents |
|
|
141 | Topical steroids with anti infectives |
|
|
147 | Opthalmic preparations |
|
|
151 | Vaginal preparations |
|
|
154 | Loop diuretics |
|
|
155 | Potassium-sparing diuretics |
|
|
156 | Thiazide and thiazide-like diuretics |
|
|
159 | First generation cephalosporins |
|
|
160 | Second generation cephalosporins |
|
|
163 | Ophthalmic anti-infectives |
|
|
164 | Opthalmic glaucoma agents |
|
|
165 | Opthalmic steroids |
|
|
169 | Miscellaneous opthalmic agents |
|
|
173 | HMG-CoA reductase inhibitors |
|
|
174 | Miscellaneous antihyperlipidemic agents |
|
|
177 | Miscellaneous antivirals |
|
|
178 | Skeletal muscle relaxants |
|
|
180 | Adrenergic bronchodilators |
|
|
181 | Bronchodilator combinations |
|
|
192 | Antirheumatics |
|
|
193 | Antimigraine agents |
|
|
194 | Antigout agents |
|
|
198 | Miscellaneous antiemetics |
|
|
203 | Benzodiazepine anticonvulsants |
|
|
205 | Anticholinergic antiparkinson agents |
|
|
208 | SSRI antidepressants |
|
|
209 | Tricyclic antidepressants |
|
|
210 | Phenothiazine antipsychotics |
|
|
211 | Platelet aggregation inhibitors |
|
|
213 | Sulfonylureas |
|
|
214 | Biguanides |
|
|
215 | Insulin |
|
|
216 | Alpha-glucosidase inhibitors |
|
|
217 | Bisphosphonates |
|
|
219 | Nutraceutical products |
|
|
220 | Herbal products |
|
|
224 | Aminopenicillins |
|
|
229 | Purine nucleosides |
|
|
232 | Rifamycin derivatives |
|
|
234 | Miscellaneous antituberculosis agents |
|
|
236 | Azole antifungals |
|
|
237 | Miscellaneous antifungals |
|
|
241 | Fibric acid derivatives |
|
|
243 | Leukotriene modifiers |
|
|
245 | Nasal steroids |
|
|
247 | Nasal preparations |
|
|
248 | Topical emollients |
|
|
249 | Antidepressants |
|
|
251 | Antipsychotics |
|
|
262 | Coumarins and indandiones |
|
|
264 | Urinary antispasmodics |
|
|
265 | Urinary pH modifiers |
|
|
267 | Opthalmic antihistamines and decongestants |
|
|
268 | Vaginal anti-infectives |
|
|
270 | Antipsoriatics |
|
|
271 | Thiazolidinediones |
|
|
272 | Proton pump inhibitors |
|
|
274 | Cardioselective beta blockers |
|
|
275 | Non-cardioselective beta blockers |
|
|
277 | 5-aminosalicylates |
|
|
278 | COX-2 inhibitors |
|
|
279 | Gonadotropin-releasing hormone and analogs |
|
|
282 | Meglitinides |
|
|
284 | Viscosupplementation agents |
|
|
286 | Mydriatics |
|
|
288 | 5-alpha-reductase inhibitors |
|
|
289 | Antihyperuricemic agents |
|
|
292 | Topical antifungals |
|
|
296 | Inhaled corticosteroids |
|
|
299 | Anticholinergic bronchodilators |
|
|
301 | Glucocorticoids |
|
|
304 | Macrolides |
|
|
306 | Phenylpiperazine antidepressants |
|
|
307 | Tetracyclic antidepressants |
|
|
308 | SSNRI antidepressants |
|
|
311 | Dibenzazepine anticonvulsants |
|
|
316 | Cholesterol absorption inhibitors |
|
|
332 | Radiologic adjuncts |
|
|
340 | Aldosterone receptor antagonists |
|
|
341 | Atypical antipsychotics |
|
|
345 | Fatty acid derivative anticonvulsants |
|
|
347 | Gamma-aminobutyric acid analogs |
|
|
348 | Triazine anticonvulsants |
|
|
351 | Carbonic anhydrase inhibitor anticonvulsants |
|
|
363 | Probiotics |
|
|
371 | Dipeptidyl peptidase 4 inhibitors |
|
|
374 | Cardiac stressing agents |
|
|
381 | Topical depigmenting agents |
|
|
382 | Topical antihistamines |
|
|
385 | Group I antiarrhythmics |
|
|
387 | Group III antiarrhythmics |
|
|
388 | Group IV antiarrhythmics |
|
|
389 | Group V antiarrhythmics |
|
|
409 | Bone resorption inhibitors |
|
|
417 | Selective estrogen receptor modulators |
|
|
418 | Parathyroid hormone and analogs |
|
|
423 | Aromatase inhibitors |
|
|
441 | Calcineurin inhibitors |
|
|
445 | Other immunosuppressants |
|
|
448 | Topical non-steroidal anti-inflammatories |
|
|
457 | Hydrazide derivatives |
|
|
999 | Inapp |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
Survey of Midlife in Japan (MIDJA): Biomarker Project, 2009-2010 (ICPSR 34969)/#/0002_Stacked_Medication_Data_J2MTC1S1 | MIDUS-study_name+variable_name | ICPSR 34969 |